Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 45% ± 14% | |
peripheral blood | 17 studies | 37% ± 11% | |
brain | 11 studies | 29% ± 14% | |
intestine | 10 studies | 31% ± 10% | |
kidney | 9 studies | 35% ± 16% | |
eye | 8 studies | 40% ± 20% | |
liver | 6 studies | 36% ± 10% | |
heart | 5 studies | 24% ± 4% | |
uterus | 5 studies | 54% ± 10% | |
adipose | 5 studies | 39% ± 21% | |
prostate | 5 studies | 59% ± 24% | |
lymph node | 5 studies | 41% ± 17% | |
pancreas | 4 studies | 67% ± 12% | |
placenta | 4 studies | 52% ± 20% | |
esophagus | 4 studies | 33% ± 16% | |
breast | 4 studies | 61% ± 6% | |
bone marrow | 3 studies | 35% ± 14% | |
adrenal gland | 3 studies | 37% ± 9% | |
skin | 3 studies | 55% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 10309.07 | 1443 / 1445 | 100% | 91.87 | 183 / 183 |
stomach | 100% | 10329.99 | 359 / 359 | 100% | 105.23 | 285 / 286 |
skin | 100% | 10850.46 | 1808 / 1809 | 99% | 149.94 | 469 / 472 |
intestine | 100% | 10245.67 | 966 / 966 | 99% | 101.77 | 523 / 527 |
thymus | 100% | 15341.22 | 653 / 653 | 99% | 149.31 | 600 / 605 |
lung | 100% | 12793.99 | 576 / 578 | 99% | 110.15 | 1147 / 1155 |
ovary | 100% | 10711.72 | 180 / 180 | 99% | 94.46 | 425 / 430 |
breast | 100% | 13218.89 | 459 / 459 | 99% | 100.91 | 1103 / 1118 |
kidney | 100% | 9736.67 | 89 / 89 | 98% | 108.60 | 886 / 901 |
prostate | 100% | 9497.80 | 244 / 245 | 98% | 79.49 | 494 / 502 |
liver | 100% | 9494.24 | 225 / 226 | 98% | 200.98 | 399 / 406 |
pancreas | 99% | 7369.69 | 324 / 328 | 99% | 96.90 | 176 / 178 |
bladder | 100% | 15347.67 | 21 / 21 | 97% | 87.83 | 490 / 504 |
brain | 97% | 6195.43 | 2561 / 2642 | 100% | 74.41 | 702 / 705 |
adrenal gland | 100% | 22644.10 | 258 / 258 | 96% | 103.99 | 221 / 230 |
uterus | 100% | 11001.87 | 170 / 170 | 96% | 81.88 | 440 / 459 |
adipose | 100% | 14583.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 15728.39 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 175.06 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 75.70 | 29 / 29 |
muscle | 100% | 32102.13 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7869.49 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.72 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 82.18 | 44 / 45 |
peripheral blood | 97% | 6343.59 | 899 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 9323.42 | 814 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097009 | Biological process | energy homeostasis |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0000425 | Biological process | pexophagy |
GO_0010821 | Biological process | regulation of mitochondrion organization |
GO_0061635 | Biological process | regulation of protein complex stability |
GO_0016236 | Biological process | macroautophagy |
GO_0070342 | Biological process | brown fat cell proliferation |
GO_0035973 | Biological process | aggrephagy |
GO_1900273 | Biological process | positive regulation of long-term synaptic potentiation |
GO_0030163 | Biological process | protein catabolic process |
GO_0001659 | Biological process | temperature homeostasis |
GO_0000423 | Biological process | mitophagy |
GO_0006914 | Biological process | autophagy |
GO_0098780 | Biological process | response to mitochondrial depolarisation |
GO_0002931 | Biological process | response to ischemia |
GO_0046578 | Biological process | regulation of Ras protein signal transduction |
GO_1905719 | Biological process | protein localization to perinuclear region of cytoplasm |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0006606 | Biological process | protein import into nucleus |
GO_0007032 | Biological process | endosome organization |
GO_0000422 | Biological process | autophagy of mitochondrion |
GO_0043122 | Biological process | regulation of canonical NF-kappaB signal transduction |
GO_0140694 | Biological process | non-membrane-bounded organelle assembly |
GO_0002376 | Biological process | immune system process |
GO_0110076 | Biological process | negative regulation of ferroptosis |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0016197 | Biological process | endosomal transport |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0071211 | Biological process | protein targeting to vacuole involved in autophagy |
GO_0034144 | Biological process | negative regulation of toll-like receptor 4 signaling pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0030154 | Biological process | cell differentiation |
GO_0006915 | Biological process | apoptotic process |
GO_0008104 | Biological process | protein localization |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0000932 | Cellular component | P-body |
GO_0016605 | Cellular component | PML body |
GO_0044754 | Cellular component | autolysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030017 | Cellular component | sarcomere |
GO_0005770 | Cellular component | late endosome |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0044753 | Cellular component | amphisome |
GO_0097225 | Cellular component | sperm midpiece |
GO_0097413 | Cellular component | Lewy body |
GO_0005739 | Cellular component | mitochondrion |
GO_0016234 | Cellular component | inclusion body |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0043232 | Cellular component | intracellular non-membrane-bounded organelle |
GO_0005776 | Cellular component | autophagosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000407 | Cellular component | phagophore assembly site |
GO_0016235 | Cellular component | aggresome |
GO_0042802 | Molecular function | identical protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042169 | Molecular function | SH2 domain binding |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0140311 | Molecular function | protein sequestering activity |
GO_0140313 | Molecular function | molecular sequestering activity |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0043130 | Molecular function | ubiquitin binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0070530 | Molecular function | K63-linked polyubiquitin modification-dependent protein binding |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0035255 | Molecular function | ionotropic glutamate receptor binding |
GO_0140036 | Molecular function | ubiquitin-modified protein reader activity |
Gene name | SQSTM1 |
Protein name | Sequestosome 1 Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62) |
Synonyms | ORCA OSIL |
Description | FUNCTION: Molecular adapter required for selective macroautophagy (aggrephagy) by acting as a a bridge between polyubiquitinated proteins and autophagosomes . Promotes the recruitment of ubiquitinated cargo proteins to autophagosomes via multiple domains that bridge proteins and organelles in different steps . SQSTM1 first mediates the assembly and removal of ubiquitinated proteins by undergoing liquid-liquid phase separation upon binding to ubiquitinated proteins via its UBA domain, leading to the formation of insoluble cytoplasmic inclusions, known as p62 bodies . SQSTM1 then interacts with ATG8 family proteins on autophagosomes via its LIR motif, leading to p62 body recruitment to autophagosomes, followed by autophagic clearance of ubiquitinated proteins . SQSTM1 is itself degraded along with its ubiquitinated cargos . Also required to recruit ubiquitinated proteins to PML bodies in the nucleus . Also involved in autophagy of peroxisomes (pexophagy) in response to reactive oxygen species (ROS) by acting as a bridge between ubiquitinated PEX5 receptor and autophagosomes . Acts as an activator of the NFE2L2/NRF2 pathway via interaction with KEAP1: interaction inactivates the BCR(KEAP1) complex by sequestering the complex in inclusion bodies, promoting nuclear accumulation of NFE2L2/NRF2 and subsequent expression of cytoprotective genes . Promotes relocalization of 'Lys-63'-linked ubiquitinated STING1 to autophagosomes . Involved in endosome organization by retaining vesicles in the perinuclear cloud: following ubiquitination by RNF26, attracts specific vesicle-associated adapters, forming a molecular bridge that restrains cognate vesicles in the perinuclear region and organizes the endosomal pathway for efficient cargo transport . Sequesters tensin TNS2 into cytoplasmic puncta, promoting TNS2 ubiquitination and proteasomal degradation . May regulate the activation of NFKB1 by TNF-alpha, nerve growth factor (NGF) and interleukin-1 . May play a role in titin/TTN downstream signaling in muscle cells . Adapter that mediates the interaction between TRAF6 and CYLD (By similarity). . |
Accessions | ENST00000514093.5 ENST00000453046.5 C9J6J8 ENST00000626660.1 D6RBF1 ENST00000422245.5 ENST00000360718.5 [Q13501-2] ENST00000510187.5 ENST00000508284.5 ENST00000504627.1 ENST00000643389.2 [Q13501-1] ENST00000640444.2 [Q13501-1] Q13501 C9JRJ8 E9PFW8 E3W990 E7EMC7 ENST00000389805.9 [Q13501-1] |